1. Report Introduction
2. Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology Overview at a Glance
3. Market Share Distribution of Secondary Progressive Multiple Sclerosis (SPMS)
4. Disease Background and Overview: Secondary Progressive Multiple Sclerosis (SPMS)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Secondary Progressive Multiple Sclerosis (SPMS) by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
7.3. Sub-Type Specific cases of Secondary Progressive Multiple Sclerosis (SPMS)*
7.4. Sex- Specific Cases of Secondary Progressive Multiple Sclerosis (SPMS)*
7.5. Diagnosed Cases of Secondary Progressive Multiple Sclerosis (SPMS)
7.6. Treated Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.1.3. Sub-Type Specific cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.1.4. Sex- Specific Cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.1.5. Diagnosed Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.1.6. Treated Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.2.3. Sub-Type Specific cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.2.4. Sex- Specific Cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.2.5. Diagnosed Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.2.6. Treated Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.3.3. Sub-Type Specific cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.3.4. Sex- Specific Cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.3.5. Diagnosed Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.3.6. Treated Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.4.3. Sub-Type Specific cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.4.4. Sex- Specific Cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.4.5. Diagnosed Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.4.6. Treated Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.5.3. Sub-Type Specific cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.5.4. Sex- Specific Cases of Secondary Progressive Multiple Sclerosis (SPMS)*
8.5.5. Diagnosed Cases of Secondary Progressive Multiple Sclerosis (SPMS)
8.5.6. Treated Cases of Secondary Progressive Multiple Sclerosis (SPMS)
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
9.3. Sub-Type Specific cases of Secondary Progressive Multiple Sclerosis (SPMS)*
9.4. Sex- Specific Cases of Secondary Progressive Multiple Sclerosis (SPMS)*
9.5. Diagnosed Cases of Secondary Progressive Multiple Sclerosis (SPMS)
9.6. Treated Cases of Secondary Progressive Multiple Sclerosis (SPMS)
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.